PCSCs with high tumor-initiating and metastatic capacities are enriched in the side population (Patrawala et al., 2005), CD44+ (Patrawala et al., 2006), and CD44+α2β1+ (Patrawala et al., 2007) subpopulations. Here, CD44 is linked to neoplasm.